RE: cash burn26 Jan 2023 11:45
They spent way more in R&D than in the previous years.
From the Novacyt S.A. (NVYTF) Q2 2022 Earnings Call Transcript, i read that R&D and commercials spendings are about around 5m for 2022.
In h1 2022, RD costs were 70% or so higher than in the previous year.
That wont surely be every year.
Then, the ltip Was to be paid in 2022 too.
Im not very alarmed in the use of the cash atm.
Of course, like captainswag told, i would have like to see,but surely like everybody too, a use of cash for aquisition.
One day maybe...